She Signed a Living Will. Her Sister Didn’t Honor It.
A court ruling bolsters a key estate-planning move—and shows where it can fall short
Related Articles
Mayo Genetic Risk Models for Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax + Hypomethylating Agent
The Mayo genetic risk models offer pre-treatment and response-based prognostic tools for newly diagnosed AML treated with Ven-HMA.
Thrombosis and Hemostasis Conference | ISTH 2025 Congress
The ISTH 2025 Congress is the premier international medical and scientific conference for experts in the fields of thrombosis, hemostasis and vascular biology. Join us…
Weekly Low-Dose Regimen of Decitabine and Venetoclax as Effective as Higher Dose | ASH Clinical News | American Society of Hematology
Lara C. Pullen, PhD, is a freelance medical writer in Chicago, Illinois. A metronomic, low-dose schedule of decitabine and venetoclax was deemed to be a…
Radon Exposure and Gestational Diabetes
This study investigates whether US county-level radon measurements are associated with gestational diabetes among nulliparous pregnant individuals.
Dummies Guide to “The British Professor Leading the Controversial Backlash Against Antidepressants”
British journalists and editors, this is for you
Do antidepressants work? This British professor says they don’t
Joanna Moncrieff is a professor and NHS psychiatrist who dared to argue that depression is not a physical illness. As a result she has been…
PROFID EHRA: The Most Important Trial of the Decade in Cardiology
The PROFID EHRA trial will test the benefit of an implantable cardioverter defibrillator in patients who have LV dysfunction after an MI.
The Coolest Mobile Gadgets We Saw at CES
From a dongle that lets your phone connect to satellites to a phone that can change its display with the flip of a switch, these…
